These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 10678579

  • 1. Molecular pathology of cyclooxygenase-2 in neoplasia.
    Fosslien E.
    Ann Clin Lab Sci; 2000 Jan; 30(1):3-21. PubMed ID: 10678579
    [Abstract] [Full Text] [Related]

  • 2. Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis.
    Fosslien E.
    Ann Clin Lab Sci; 2001 Oct; 31(4):325-48. PubMed ID: 11688844
    [Abstract] [Full Text] [Related]

  • 3. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.
    Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270
    [Abstract] [Full Text] [Related]

  • 4. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
    Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park B, Heo DS, Kim KH.
    Anticancer Res; 2002 Nov 15; 22(4):2089-96. PubMed ID: 12174888
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA.
    Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis.
    Tsuji S, Tsujii M, Kawano S, Hori M.
    J Exp Clin Cancer Res; 2001 Mar 01; 20(1):117-29. PubMed ID: 11370818
    [Abstract] [Full Text] [Related]

  • 13. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
    Shamma A, Yamamoto H, Doki Y, Okami J, Kondo M, Fujiwara Y, Yano M, Inoue M, Matsuura N, Shiozaki H, Monden M.
    Clin Cancer Res; 2000 Apr 15; 6(4):1229-38. PubMed ID: 10778945
    [Abstract] [Full Text] [Related]

  • 20. The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.
    Stoner GD, Qin H, Chen T, Carlton PS, Rose ME, Aziz RM, Dixit R.
    Carcinogenesis; 2005 Sep 15; 26(9):1590-5. PubMed ID: 15878914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.